CN1077122A - A kind of compound anticancer capsule preparation - Google Patents
A kind of compound anticancer capsule preparation Download PDFInfo
- Publication number
- CN1077122A CN1077122A CN 92102701 CN92102701A CN1077122A CN 1077122 A CN1077122 A CN 1077122A CN 92102701 CN92102701 CN 92102701 CN 92102701 A CN92102701 A CN 92102701A CN 1077122 A CN1077122 A CN 1077122A
- Authority
- CN
- China
- Prior art keywords
- mylabris
- herba
- radix
- water
- rice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of formulation method for the treatment of the compound capsule of cancer, be particularly useful for treating pulmonary carcinoma, colorectal cancer.Compound capsule component of the present invention is made up of Mylabris, Venenum Bufonis, Herba Scutellariae Barbatae, Hedyotidis Diffusae, Herba Solani Lyrati, Radix Ginseng, the Radix Astragali etc., technical processs such as preparation method comprises pulverizing, extraction, concentrates, granulation, through clinical verification, cure and obvious effective rate 12.6%, have no adverse reaction, strengthening vital QI to eliminate pathogenic factors, do not damage resistance of human body, do not damage the human immunity factor.
Description
The present invention relates to a kind of compound anticancer capsule preparation method, belong to drug formulation process.
At present, malignant tumor does not worldwide still find the way of better radical cure, the Chemo-Therapy therapy has side effects bigger, and adopting drug matching treatment cancer card great advantage is strengthening vital QI to eliminate pathogenic factors, does not damage the resistance of human body, do not damage the human immunity factor, kill and wound cancerous cell to greatest extent, at present anticancer openly to report more be anticancer " beauty " capsule to Chinese medicine, and this medicine is put into serial production, " beauty " capsule mainly is the treatment esophageal carcinoma, cures obvious effective rate CR+PR=3.2%.
The object of the present invention is to provide a kind of treatment pulmonary carcinoma compound capsule method, the strengthening vital QI to eliminate pathogenic factors that utilizes the medicine active ingredient to produce, heat-clearing and toxic substances removing, blood-activating analgetic, air making-up and spleen enlivening, the functions such as kidney nourishes blood of overflowing reach and delay the cancer diffusion, alleviate slight illness, effectively the purpose of treatment.
Technical scheme of the present invention is achieved in that the composition of the compound medical capsule of this treatment cancer comprises Mylabris 0.05-0.06%, Venenum Bufonis 0.05-0.06%, Herba Scutellariae Barbatae 10-15%, Hedyotidis Diffusae 10-15%, Herba Solani Lyrati 10-15%, Radix Ginseng 2-3%.Radix Astragali 25-30%, Fructus Ligustri Lucidi 20-25%, Moschus 0.1-0.5%, Borneolum Syntheticum 0.05-0.1%, artificial Calculus Bovis 0.9-1.1%, Herba Schizonepetae 5.0-6.0%, Radix Saposhnikoviae 5.0-6.0%.The formulation method that the present invention treats the compound medical capsule of cancer is divided into several parts, at first Mylabris being removed sufficient wing, Semen setariae puts a pot internal heating and sprays water that a little is pasted on the pot to rice, the time cigarette adds Mylabris when emerging, stir-fries with the sallow degree of being of rice gently, takes out and removes the grain of rice, pulverizing, sieving for standby;
With Moschus, artificial Calculus Bovis, Venenum Bufonis, Borneolum Syntheticum, Radix Ginseng, Herba Schizonepetae be developed into fine powder respectively, sieve standby with the Mylabris mixing; Radix Saposhnikoviae elder generation water is moistening, feed superheated steam, volatile oil is distillated through condenser; The Radix Saposhnikoviae medicinal residues that extract volatile oil were extracted 2 hours with the decocting in water that Herba Scutellariae Barbatae, the Radix Astragali, Hedyotidis Diffusae, Herba Solani Lyrati, Fructus Ligustri Lucidi add 10 times of amounts again; the decocting in water that adds for the second time 8 times of amounts extracted 2 hours; filtration, merging filtrate; concentrating under reduced pressure becomes cream, drying, pulverizing to add Moschus, artificial Calculus Bovis, Venenum Bufonis, Borneolum Syntheticum, Radix Ginseng, Herba Schizonepetae, Mylabris fine powder mixing; granulate; spray adds Radix Saposhnikoviae volatile oil, and mixing dress enteric coated capsule promptly.
Compound anti-cancer capsule preparation commodity of the present invention Tai Ji pellet by name is produced by pharmaceutical factory, through Shanghai Institute of Pharmaceutical Industry, the basic non-toxic type medicine of genus of institute of materia medica, Tianjin, Chinese medical courses in general institute resources of medicinal plant toxicity that developmental research is carried out, pharmacological research proof is to S
180, HAC, Lemis lung and L
7712Tumor models such as leukemia have than the obvious suppression effect, and obvious effective rate CR+PR=12.6% is cured in clinical practice, and is apparent in view to effects such as pulmonary carcinoma, colorectal cancer, breast carcinoma.
Describe content of the present invention in detail below in conjunction with embodiment.
1, prescription:
Mylabris 1g, Venenum Bufonis 1g, Herba Scutellariae Barbatae 235g, Hedyotidis Diffusae 235g, Herba Solani Lyrati 235g, Radix Ginseng 50g, Radix Astragali 505g, Fructus Ligustri Lucidi 470g, Moschus 2.4g, Borneolum Syntheticum 1.2g, artificial Calculus Bovis 19.2g, Herba Schizonepetae 100g, Radix Saposhnikoviae 1.2g.
2, method for making:
1, Mylabris rice is fried: Mylabris is chosen clean impurity, remove sufficient wing, Semen setariae and put a pot internal heating and spray water that a little is pasted on the pot to rice, add Mylabris when marquis's cigarette is emerged, stir-fry with sallow be the degree of rice gently, the grain of rice is removed in taking-up, pulverizing, sieving for standby;
2, Moschus, artificial Calculus Bovis, Venenum Bufonis, Borneolum Syntheticum, Radix Ginseng, Herba Schizonepetae are ground into fine powder respectively, sieve standby with the Mylabris mixing;
3, Radix Saposhnikoviae elder generation water is moistening, feed superheated steam, volatile oil is distillated through condenser;
4, the Radix Saposhnikoviae medicinal residues that will extract behind the volatile oil extracted 2 hours with the decocting in water that Herba Scutellariae Barbatae, the Radix Astragali, Hedyotidis Diffusae, Herba Solani Lyrati, Fructus Ligustri Lucidi add 10 times of amounts again; the decocting in water that adds for the second time 8 times of amounts extracted 2 hours; filtration, merging filtrate; concentrating under reduced pressure becomes cream, drying, pulverizing to add Moschus, artificial Calculus Bovis, Venenum Bufonis, Borneolum Syntheticum, Radix Ginseng, Herba Schizonepetae, Mylabris fine powder mixing; granulate; spray adds Radix Saposhnikoviae volatile oil, and mixing dress enteric coated capsule promptly.
Claims (2)
1, a kind of compound anticancer capsule preparation, its composition comprises Mylabris 0.05-0.06%, Venenum Bufonis 0.05-0.06%, Herba Scutellariae Barbatae 10-15%, Hedyotidis Diffusae 10-15%, Herba Solani Lyrati 10-15%, Radix Ginseng 2-3%.Radix Astragali 25-30%, Fructus Ligustri Lucidi 20-25%, Moschus 0.1-0.5%, Borneolum Syntheticum 0.05-0.1%, artificial Calculus Bovis 0.9-1.1%, Herba Schizonepetae 5.0-6.0%, Radix Saposhnikoviae 5.0-6.0%.
2, a kind of compound anticancer capsule preparation method is characterized in that Mylabris is removed sufficient wing, Semen setariae puts a pot internal heating and spray water that a little is pasted on the pot to rice, waits when cigarette is emerged to add Mylabris, stir-fry with sallow be the degree of rice gently, and the grain of rice is removed in taking-up, pulverizing, sieving for standby;
With Moschus, artificial Calculus Bovis, Venenum Bufonis, Borneolum Syntheticum, Radix Ginseng, Herba Schizonepetae be ground into fine powder respectively, sieve standby with the Mylabris mixing;
Radix Saposhnikoviae elder generation water is moistening, feed superheated steam, volatile oil is distillated through condenser;
The Radix Saposhnikoviae medicinal residues that extract volatile oil were extracted 2 hours with the decocting in water that Herba Scutellariae Barbatae, the Radix Astragali, Hedyotidis Diffusae, Herba Solani Lyrati, Fructus Ligustri Lucidi add 10 times of amounts again; the decocting in water that adds for the second time 8 times of amounts extracted 2 hours; filtration, merging filtrate; concentrating under reduced pressure becomes cream, drying, pulverizing to add Moschus, artificial Calculus Bovis, Venenum Bufonis, Borneolum Syntheticum, Radix Ginseng, Herba Schizonepetae, Mylabris fine powder mixing; granulate; spray adds Radix Saposhnikoviae volatile oil, and mixing dress enteric coated capsule promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 92102701 CN1077122A (en) | 1992-04-11 | 1992-04-11 | A kind of compound anticancer capsule preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 92102701 CN1077122A (en) | 1992-04-11 | 1992-04-11 | A kind of compound anticancer capsule preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1077122A true CN1077122A (en) | 1993-10-13 |
Family
ID=4939794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 92102701 Pending CN1077122A (en) | 1992-04-11 | 1992-04-11 | A kind of compound anticancer capsule preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1077122A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1049827C (en) * | 1994-06-06 | 2000-03-01 | 郭文峰 | Anti-cancer powder |
CN1051015C (en) * | 1996-04-26 | 2000-04-05 | 陈启志 | Health care tea for anti-tumour |
CN1059565C (en) * | 1994-08-17 | 2000-12-20 | 方敏轩 | Powder for treatment of cancer and its preparing process |
CN1059800C (en) * | 1994-02-26 | 2000-12-27 | 谢岩 | Injection containing ginseng and astragalus root components |
CN1060064C (en) * | 1995-09-22 | 2001-01-03 | 周文德 | Non-toxic sedative anticancer Chinese medicine capsule |
CN1084626C (en) * | 1997-08-25 | 2002-05-15 | 高贵 | Granulated preparation for promoting blood-circulation and removing blood stasis |
WO2009036772A1 (en) | 2007-09-21 | 2009-03-26 | Pharmabrand S.A. | Anti-aids, anti-tumour, immune-system-stimulating herbal composition and production method therefor |
-
1992
- 1992-04-11 CN CN 92102701 patent/CN1077122A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1059800C (en) * | 1994-02-26 | 2000-12-27 | 谢岩 | Injection containing ginseng and astragalus root components |
CN1049827C (en) * | 1994-06-06 | 2000-03-01 | 郭文峰 | Anti-cancer powder |
CN1059565C (en) * | 1994-08-17 | 2000-12-20 | 方敏轩 | Powder for treatment of cancer and its preparing process |
CN1060064C (en) * | 1995-09-22 | 2001-01-03 | 周文德 | Non-toxic sedative anticancer Chinese medicine capsule |
CN1051015C (en) * | 1996-04-26 | 2000-04-05 | 陈启志 | Health care tea for anti-tumour |
CN1084626C (en) * | 1997-08-25 | 2002-05-15 | 高贵 | Granulated preparation for promoting blood-circulation and removing blood stasis |
WO2009036772A1 (en) | 2007-09-21 | 2009-03-26 | Pharmabrand S.A. | Anti-aids, anti-tumour, immune-system-stimulating herbal composition and production method therefor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1819836A (en) | A Chinese medicinal preparation for treating lung cancer and its preparation method | |
CN108029821A (en) | Bark of eucommia solid health-care tea and preparation method thereof | |
CN102552638B (en) | Anticancer drug, as well as preparation method and application of same | |
CN1077122A (en) | A kind of compound anticancer capsule preparation | |
CN102824629A (en) | Immune hematogenesis anti-cancer preparation for treating leukemia and preparation method thereof | |
CN103169815A (en) | Radix tetrastigme lozenge and preparation method thereof | |
CN1228063C (en) | Medicine for treating liver disease | |
CN101264164A (en) | Medicinal composition for treating tumor and preparation thereof | |
CN1408383A (en) | Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method | |
CN1233477A (en) | Medicine for treating hepatitis and liver fibrosis, and method for preparing same | |
CN1250254C (en) | Medicine for promoting wound healing | |
CN101181564A (en) | Chinese medicine compound preparations with antineoplastic activity | |
CN1408384A (en) | Pure traditional Chinese medicine preparation for curing lung cancer | |
CN1085439A (en) | A kind of anticancer herbal drug | |
CN1168484C (en) | Medicine for treating leukopenia caused by carcinosis radiotherapy and chemotherapy | |
CN1259344A (en) | Prepn. technique for Chinese traditional medicine capsule | |
CN1164318C (en) | Capsule for treating gynaecological inflammation | |
CN114306580A (en) | Method and process for preparing compound paclitaxel anti-leukemia capsule tablet | |
CN1754550B (en) | Compound traditional Chinese medicine glossy ganoderma formulation and preparation method | |
CN1179325A (en) | Medicine for radical treatment of psoriasis and preparing process thereof | |
CN1122527C (en) | Medicine for curing prostatosis | |
CN101259235A (en) | Compound traditional Chinese medicine preparation for treating acute myeloblastic leukemia and producing method thereof | |
CN1083719C (en) | Sphinx extract oral liquid | |
CN112336842A (en) | Preparation method of compound ginseng donkey-hide gelatin tablet for tonifying qi and beautifying | |
CN1131049C (en) | Proriasis treating Yinxieling capsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |